Bortezomib in the management of multiple myeloma

Jacob P LaubachDepartment of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USACorrespondence[email protected]

Constantine S MitsiadesDepartment of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA

Teru HideshimaDepartment of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA

Robert SchlossmanDepartment of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA

Dharminder ChauhanDepartment of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA

Nikhil MunshiDepartment of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA

Irene GhobrialDepartment of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA

Nicole CarreauDepartment of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA

Kenneth C AndersonDepartment of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA

Paul G RichardsonDepartment of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA

Your download is now in progress and you may close this window